Business Description
COSMOS Pharmaceutical Corp
ISIN : JP3298400007
Share Class Description:
CSMYF: Ordinary SharesCompare
Compare
Traded in other countries / regions
3349.JapanCSMYF.USA IPO Date
2014-06-04Description
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company places a emphasis on convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. Cosmos also operates a private grocery brand called ON 365.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.54 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.15 | |||||
| Debt-to-EBITDA | 0.61 | |||||
| Interest Coverage | 262.23 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.13 | |||||
| Beneish M-Score | -2.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.9 | |||||
| 3-Year EBITDA Growth Rate | 0.8 | |||||
| 3-Year EPS without NRI Growth Rate | -0.5 | |||||
| 3-Year Book Growth Rate | 10.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 7.91 | |||||
| Future 3-5Y Total Revenue Growth Rate | 8 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -20.06 | |||||
| 12-1 Month Momentum % | -20.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.72 | |||||
| Quick Ratio | 0.32 | |||||
| Cash Ratio | 0.25 | |||||
| Days Inventory | 38.04 | |||||
| Days Sales Outstanding | 0.2 | |||||
| Days Payable | 77.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Payout Ratio | 0.18 | |||||
| 3-Year Dividend Growth Rate | 29.7 | |||||
| Shareholder Yield % | -0.76 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 19.88 | |||||
| Operating Margin % | 3.46 | |||||
| Net Margin % | 2.65 | |||||
| FCF Margin % | -0.06 | |||||
| ROE % | 11.83 | |||||
| ROA % | 5.93 | |||||
| ROIC % | 7.58 | |||||
| ROC (Joel Greenblatt) % | 12.35 | |||||
| ROCE % | 15.07 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.4 | |||||
| Forward PE Ratio | 17.41 | |||||
| PE Ratio without NRI | 20.97 | |||||
| Shiller PE Ratio | 26.14 | |||||
| PEG Ratio | 4.03 | |||||
| PS Ratio | 0.57 | |||||
| PB Ratio | 2.41 | |||||
| Price-to-Tangible-Book | 2.42 | |||||
| Price-to-Operating-Cash-Flow | 10.12 | |||||
| EV-to-EBIT | 14.89 | |||||
| EV-to-Forward-EBIT | 14.39 | |||||
| EV-to-EBITDA | 9.61 | |||||
| EV-to-Forward-EBITDA | 9.13 | |||||
| EV-to-Revenue | 0.55 | |||||
| EV-to-Forward-Revenue | 0.52 | |||||
| EV-to-FCF | -850.6 | |||||
| Price-to-Projected-FCF | 2.12 | |||||
| Price-to-DCF (Earnings Based) | 0.79 | |||||
| Price-to-Median-PS-Value | 0.71 | |||||
| Price-to-Peter-Lynch-Fair-Value | 4.08 | |||||
| Price-to-Graham-Number | 1.55 | |||||
| Earnings Yield (Greenblatt) % | 6.72 | |||||
| FCF Yield % | -0.11 | |||||
| Forward Rate of Return (Yacktman) % | 6.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CSMYF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
COSMOS Pharmaceutical Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 6,557.212 | ||
| EPS (TTM) ($) | 2.191 | ||
| Beta | 0 | ||
| Volatility % | 20.15 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.000495 | ||
| 20-Day SMA ($) | 39.3 | ||
| 12-1 Month Momentum % | -20.06 | ||
| 52-Week Range ($) | 39.3 - 49.16 | ||
| Shares Outstanding (Mil) | 79.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
COSMOS Pharmaceutical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
COSMOS Pharmaceutical Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
COSMOS Pharmaceutical Corp Frequently Asked Questions
What is COSMOS Pharmaceutical Corp(CSMYF)'s stock price today?
The current price of CSMYF is $39.30. The 52 week high of CSMYF is $49.16 and 52 week low is $39.30.
When is next earnings date of COSMOS Pharmaceutical Corp(CSMYF)?
The next earnings date of COSMOS Pharmaceutical Corp(CSMYF) is .
Does COSMOS Pharmaceutical Corp(CSMYF) pay dividends? If so, how much?
COSMOS Pharmaceutical Corp(CSMYF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers